Multiple myeloma - lenalidomide (maintenance, post autologous stem cell transplantation) – final appraisal Determination

DRAFT NICE guidance recommends lenalidomide as maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple myeloma in adults, only if the dosage schedule is 10 mg per day on days 1 to 21 of a 28-day cycle.

Source:

National Institute for Health and Care Excellence